Tags

Type your tag names separated by a space and hit enter

Antidiarrheal drug products for over-the-counter human use; amendment of final monograph. Final rule.
Fed Regist. 2004 May 12; 69(92):26301-2.FR

Abstract

The Food and Drug Administration (FDA) is issuing a final rule amending the final monograph (FM) for over-the-counter (OTC) antidiarrheal drug products to include relief of travelers' diarrhea as an indication for products containing bismuth subsalicylate. Travelers' diarrhea occurs in travelers and is most commonly caused by an infectious agent. This final rule is part of FDA's ongoing review of OTC drug products.

Authors

Food and Drug Administration, HHS
No affiliation info available

MeSH

AntidiarrhealsDiarrheaDrug LabelingHumansLegislation, DrugNonprescription DrugsSalicylatesTravelUnited StatesUnited States Food and Drug Administration

Pub Type(s)

Journal Article

Language

eng

PubMed ID

15141675

Citation

Food and Drug Administration, HHS. "Antidiarrheal Drug Products for Over-the-counter Human Use; Amendment of Final Monograph. Final Rule." Federal Register, vol. 69, no. 92, 2004, pp. 26301-2.
Food and Drug Administration, HHS. Antidiarrheal drug products for over-the-counter human use; amendment of final monograph. Final rule. Fed Regist. 2004;69(92):26301-2.
Food and Drug Administration, HHS. (2004). Antidiarrheal drug products for over-the-counter human use; amendment of final monograph. Final rule. Federal Register, 69(92), 26301-2.
Food and Drug Administration, HHS. Antidiarrheal Drug Products for Over-the-counter Human Use; Amendment of Final Monograph. Final Rule. Fed Regist. 2004 May 12;69(92):26301-2. PubMed PMID: 15141675.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Antidiarrheal drug products for over-the-counter human use; amendment of final monograph. Final rule. A1 - ,, PY - 2004/5/15/pubmed PY - 2004/6/21/medline PY - 2004/5/15/entrez SP - 26301 EP - 2 JF - Federal register JO - Fed Regist VL - 69 IS - 92 N2 - The Food and Drug Administration (FDA) is issuing a final rule amending the final monograph (FM) for over-the-counter (OTC) antidiarrheal drug products to include relief of travelers' diarrhea as an indication for products containing bismuth subsalicylate. Travelers' diarrhea occurs in travelers and is most commonly caused by an infectious agent. This final rule is part of FDA's ongoing review of OTC drug products. SN - 0097-6326 UR - https://www.unboundmedicine.com/medline/citation/15141675/Antidiarrheal_drug_products_for_over_the_counter_human_use DB - PRIME DP - Unbound Medicine ER -

Related Citations

More